Enovis ENOV
NYSE ENOV
$18.61 -0.42 (-2.21%)
As of: Sep 10, 2026 · 10:52 AM EDT

Enovis (ENOV) Other Non-Current Assets (2010 - 2026)

Enovis' (ENOV) quarterly Other Non-Current Assets came in at $88.9 million in Q3 2026, down 3.81% year-over-year from $92.4 million in Q3 2025, and down 5.4% quarter-over-quarter from $94.0 million in Q2 2026.

Analysis

Enovis (ENOV) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Other Non-Current Assets for 17 consecutive years, with $88.9 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Other Non-Current Assets fell 3.81% year-over-year to $88.9 million in Q3 2026; TTM through Jul 2026 was $88.9 million, a 3.81% decrease from a year earlier, with the FY2025 full-year figure at $93.3 million, up 5.15% from the prior year.
  • Other Non-Current Assets was $88.9 million for Q3 2026 at Enovis, down from $94.0 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $374.8 million in Q2 2022 and troughed at $68.0 million in Q3 2022.
  • A 5-year average of $104.4 million and a median of $89.0 million in 2024 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets slumped 97.83% in 2022 and jumped 39.59% in 2023, its largest moves.
  • Over 5 years, Other Non-Current Assets stood at $80.3 million in 2022, then advanced by 12.41% to $90.3 million in 2023, then dropped by 1.64% to $88.8 million in 2024, then gained by 5.15% to $93.3 million in 2025, then fell by 4.77% to $88.9 million in 2026.
  • The last three Other Non-Current Assets figures came in at $88.9 million (Q3 2026), $94.0 million (Q2 2026), and $93.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 181.92 Bn 176.31 Bn 7.27 Bn -
2 Intuitive Surgical 127.64 Bn 122.42 Bn 1.96 Bn -
3 Medtronic 117.92 Bn 109.10 Bn 6.34 Bn 4.32 Bn
4 Stryker 105.39 Bn 101.91 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 64.88 Bn 64.34 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.92 Bn 45.66 Bn 1.35 Bn 616.40 Mn
7 Alcon 33.24 Bn 31.79 Bn 1.68 Bn 434.00 Mn
8 Dexcom 32.12 Bn 30.18 Bn 830.00 Mn 273.70 Mn
9 Steris 20.83 Bn 20.35 Bn 684.20 Mn 215.10 Mn
10 Enovis 1.08 Bn 1.06 Bn 359.25 Mn 88.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 88.89 Mn
Apr 3, 2026 93.96 Mn
Dec 31, 2025 93.35 Mn
Oct 3, 2025 94.56 Mn
Jul 4, 2025 92.41 Mn
Apr 4, 2025 86.74 Mn
Dec 31, 2024 88.78 Mn
Sep 27, 2024 90.32 Mn
Jun 28, 2024 88.65 Mn
Mar 29, 2024 89.19 Mn
Dec 31, 2023 90.26 Mn
Sep 29, 2023 94.94 Mn
Jun 30, 2023 88.78 Mn
Mar 31, 2023 87.87 Mn
Dec 31, 2022 80.29 Mn
Sep 30, 2022 68.01 Mn
Jul 1, 2022 88.22 Mn
Apr 1, 2022 374.82 Mn
Dec 31, 2021 3.70 Bn
Oct 1, 2021 352.37 Mn